Search research articles
Contact Us
Filters
Showing results (101-110 of 119) with videos related to
Page
of 12
Sort By:
Journal of Oncology
|
September 9, 2022
Characterization of the Newly Established Homoharringtonine- (HHT-) Resistant Cell Lines and Mechanisms of Resistance
Fenglin Li, Qing Ling, Chao Hu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 13, 2025
HERV-K TM Subunit Elicits CD8<sup>+</sup> T Cell Anergy and Tumor Immune Evasion via Targeting CD3 Coreceptor ε in AML and PDAC
Mengyuan Li, Shuwen Zheng, Qinyuan Gong, et al.
Frontiers of Medicine
|
November 18, 2021
Abivertinib inhibits megakaryocyte differentiation and platelet biogenesis
Jiansong Huang, Xin Huang, Yang Li, et al.
Biorxiv : the Preprint Server for Biology
|
December 15, 2025
Structural atlas of <i>Pakpunavirus</i> P7-1 reveals determinants of virion stability and genome ejection
Fenglin Li, Nathan Bellis, Ravi K Lokareddy, et al.
Molecular Oncology
|
December 26, 2022
ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3-ITD
Yu Qian, Xiang Zhang, Shihui Mao, et al.
Annals of Hematology
|
January 25, 2023
FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis
Shihui Mao, Yu Qian, Wenwen Wei, et al.
Journal of Translational Medicine
|
February 11, 2023
Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis
Fenglin Li, Wenle Ye, Yiyi Yao, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
February 10, 2024
High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response
Jiajia Pan, Yungui Wang, Shujuan Huang, et al.
Frontiers of Medicine
|
May 2, 2023
ACSL5, a prognostic factor in acute myeloid leukemia, modulates the activity of Wnt/β-catenin signaling by palmitoylation modification
Wenle Ye, Jinghan Wang, Jiansong Huang, et al.
Ebiomedicine
|
June 24, 2021
MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway
Qing Ling, Fenglin Li, Xiang Zhang, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 119) with videos related to
Sort By:
Page
of 12
Journal of Oncology
|
September 9, 2022
Characterization of the Newly Established Homoharringtonine- (HHT-) Resistant Cell Lines and Mechanisms of Resistance
Fenglin Li, Qing Ling, Chao Hu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 13, 2025
HERV-K TM Subunit Elicits CD8<sup>+</sup> T Cell Anergy and Tumor Immune Evasion via Targeting CD3 Coreceptor ε in AML and PDAC
Mengyuan Li, Shuwen Zheng, Qinyuan Gong, et al.
Frontiers of Medicine
|
November 18, 2021
Abivertinib inhibits megakaryocyte differentiation and platelet biogenesis
Jiansong Huang, Xin Huang, Yang Li, et al.
Biorxiv : the Preprint Server for Biology
|
December 15, 2025
Structural atlas of <i>Pakpunavirus</i> P7-1 reveals determinants of virion stability and genome ejection
Fenglin Li, Nathan Bellis, Ravi K Lokareddy, et al.
Molecular Oncology
|
December 26, 2022
ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3-ITD
Yu Qian, Xiang Zhang, Shihui Mao, et al.
Annals of Hematology
|
January 25, 2023
FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis
Shihui Mao, Yu Qian, Wenwen Wei, et al.
Journal of Translational Medicine
|
February 11, 2023
Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis
Fenglin Li, Wenle Ye, Yiyi Yao, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
February 10, 2024
High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response
Jiajia Pan, Yungui Wang, Shujuan Huang, et al.
Frontiers of Medicine
|
May 2, 2023
ACSL5, a prognostic factor in acute myeloid leukemia, modulates the activity of Wnt/β-catenin signaling by palmitoylation modification
Wenle Ye, Jinghan Wang, Jiansong Huang, et al.
Ebiomedicine
|
June 24, 2021
MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway
Qing Ling, Fenglin Li, Xiang Zhang, et al.
Page
of 12